TGFB1 and cancer: For instance, in early lesions, platelet-derived TGF-β may enforce cell-cycle arrest and induce tumor cell dormancy [37, 38], yet in advanced tumors it shields cancer cells from immune attack, and fosters an immunosuppressive tumor microenvironment (TME) [39].